Inconsistent use of epilepsy medicine could increase risk of death
NEW YORK According to a new study, epileptic patients who do not take their anti-seizure medications as prescribed could face serious or even fatal consequences, as reported by Reuters.
The study, which involved almost 34,000 patients whose records were logged into a Medicaid claims database over eight and a half years, found that when patients take their medications less than 80 percent of the time, they are three times more likely to die than when they stick to their medication plan. Moreover, not taking anti-seizure drugs also greatly increases emergency room visits and the chances of ending up in the hospital.
In addition, during periods of non-adherence, rates of emergency department visits were 50 percent higher, hospital admissions were up 86 percent, and fractures occurred at a 21 percent higher rate, than during periods of adherence.
“These results are concerning since some studies show about 30 percent to 50 percent of people with epilepsy do not take their medication regularly,” lead author Edward Faught, from the University of Alabama at Birmingham, said in a statement.
California information-sharing bill struck down by Assembly
LOS ANGELES A California bill aimed at sharing people’s prescription medication information with mass mailers did not receive a single vote of support in the Assembly Health Committee after being approved by the Senate on May 29, according to the Los Angeles Times. The bill, SB 1096, was written by Sen. Ron Calderon, D-Montebello, who will most likely not reintroduce it, even though he reserved the right to do so.
In presenting the legislation Tuesday, Calderon described it as a boon to consumers, especially those with chronic medical conditions. He said it would allow drugstores to send letters to people reminding them to take their medication or refill a prescription.
The problem with the bill, besides the fact that the patients did not want their prescription medical history shared with someone other than their doctor, is that the bill did not state who would be paying for the reminder letters and which patients would receive them.
According to the Times, it appeared that pharmaceutical companies were behind the funding in an effort to bring in more money on their respective medicines. Also, another provision stated that people who wanted to not be on the mailers would have to opt-out of the program, instead of opting into the program by stating that they would be okay with their information shared.
CCPA: track-and-trace mandate could cost pharmacies $110,000 per store
ALEXANDRIA, Va. Implementing a track-and-trace system would cost drug store chains $84,000 to $110,000 or more per store in the first year, according to a study that examined the safety of the prescription drug supply chain and the potential effects of a federally mandated system.
The study, released by the Coalition of Community Pharmacy Action, examined the safety of the prescription drug supply chain and the potential effects of a federally mandated track-and-trace system. It also found that existing security measures since 2005, including changes in state laws and steps the chains themselves have taken, have already cut the risk of counterfeit drugs entering the supply chain. The study found no cases of counterfeit drugs in the normal distribution channels since 2005, and most of the problems were from Web sites distributing drugs illegally.
The cost estimate was based on costs of computer hardware software, infrastructure, labor and other resources.
The CCPA is comprised of the National Community Pharmacists Association and the National Association of Chain Drug Stores.